Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor.
about
Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60Pilocytic astrocytoma: a disease with evolving molecular heterogeneityNCI-60 whole exome sequencing and pharmacological CellMiner analysesThe genetic architecture of multiple myeloma.Modeling anaplastic thyroid carcinoma in the mouse.Cytotoxic and genotoxic effects of 131 I and 60 Co in follicular thyroid cancer cell (WRO) with and without recombinant human thyroid-stimulating hormone treatment.Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer.The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple MyelomaMalignant Melanoma.
P2860
Q26826831-C6184928-BF7A-4C71-AB28-8F0DAEAAB492Q28286218-DE46404C-5B6A-4E66-AFA7-4AB5E41206B3Q28540834-4027466D-0172-4C12-B73B-41E1F86D0C94Q37718836-1D99ED7E-64BD-403C-BDEF-A2C3E569C93CQ38270915-457900F3-F400-49E1-94C7-EB4B384A89ACQ38701744-DE3FB89C-EFB9-472B-AA80-3F8856CCAB25Q38841033-529D23ED-6C03-4894-A440-ED169C264AC3Q42055422-585E2249-2772-4E2E-B0B9-E5D95D9A08A8Q54432652-42B22761-2368-470A-A52B-54C8C11287F0
P2860
Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor.
@en
type
label
Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor.
@en
prefLabel
Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor.
@en
P2860
P356
P1433
P1476
Vemurafenib (RG67204, PLX4032): a potent, selective BRAF kinase inhibitor
@en
P2093
Samit Patrawala
P2860
P304
P356
10.2217/FON.12.31
P407
P50
P577
2012-05-01T00:00:00Z